Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-03

Clinical Trial Update: TREATMENT OF VAGINAL DRYNESS IN SJÖGREN'S DISEASE WITH CO2-LASER VERSUS TOPICAL PROMESTRIENE [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial assessing the effectiveness of CO2-laser treatment versus topical promestriene for vaginal dryness in Sjögren's syndrome is currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Promestriene (promestriene)

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: Sjogren Syndrome, Sjogren Disease | Phase 4 | Status: RECRUITING